ALLMedicine™ First-degree Atrioventricular Block Center

Sep 1st, 2022 - A 45-year-old male with cardiac sarcoidosis verified by cardiac biopsy presented with multiple coexisting arrhythmias, including ventricular tachycardia of more than 1000 episodes per 24 h, paroxysmal atrial fibrillation, and third-degree atrioven...

Jul 27th, 2022 - Background First-degree atrioventricular (AV) block, or first-degree heart block, is defined as prolongation of the PR interval on an electrocardiogram (ECG) to more than 200 msec. [1, 2] The PR interval of the surface ECG is measured from the ons...

Jul 27th, 2022 - Background First-degree atrioventricular (AV) block, or first-degree heart block, is defined as prolongation of the PR interval on an electrocardiogram (ECG) to more than 200 msec. [1, 2] The PR interval of the surface ECG is measured from the ons...

Jul 27th, 2022 - Background First-degree atrioventricular (AV) block, or first-degree heart block, is defined as prolongation of the PR interval on an electrocardiogram (ECG) to more than 200 msec.[1, 2] The PR interval of the surface ECG is measured from the onse...

Jul 13th, 2022 - Approach Considerations A review of the patient's comorbidities and medications is essential, as oftentimes these individuals have underlying structural heart disease or coronary artery disease, or they may be taking atrioventricular (AV) node–blo...

Mar 3rd, 2022 - After approval by the Research Ethics Committee and registration of the project at ClinicalTrials (www.ClinicalTrials.gov) 75 patients will be selected from a population of obese patients scheduled for laparoscopic, bariatric or cholecystectomy su...

Aug 14th, 2019 - Rationale: Prolongation of the electrocardiographic PR interval (PR interval > 200ms; also known as first-degree atrioventricular block) is frequently encountered in clinical practice and is generally considered as a benign sign. However, there is...

Jan 18th, 2017 - Method: The following covariates will be reported. Date of diagnosis of AV-block: The date of diagnosis is defined as the day the physician diagnoses the AV-block. E.g. if the patient has a Holter monitoring performed, the date of diagnosis is the...

Jan 14th, 2022 - The combination of ibrutinib (Imbruvica) and rituximab (Rituxan) produced a high overall response rate (ORR) and durable survival in elderly patients with mantle cell lymphoma (MCL), according to data from a phase 2 ENRICH trial (NCT0180567) publi...

Nov 8th, 2021 - A man treated with the recently approved Alzheimer's drug aducanumab (Aduhelm) had six amyloid-related imaging abnormality (ARIA) episodes, researchers reported. Over 44 months in a long-term extension study, the Alzheimer's disease patient had re...

Feb 14th, 2020 - Key clinical point: Ozanimod has a superior benefit-risk profile compared with fingolimod for the treatment of relapsing multiple sclerosis (RMS). Major finding: Compared with fingolimod, ozanimod was associated with lower rates of conduction abno.

Feb 14th, 2020 - Key clinical point: Ozanimod has a superior benefit-risk profile compared with fingolimod for the treatment of relapsing multiple sclerosis (RMS). Major finding: Compared with fingolimod, ozanimod was associated with lower rates of conduction abno.

Nov 1st, 2018 - To the Editor: Pacemakers and defibrillators are common in patients presenting for cutaneous surgery. The use and application of electrosurgery in this patient population has been reviewed extensively.